InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

40
Insider
Date
Role
Action
Shares
Price
Amount
Richard M. Wright
13 Nov 2025
Former Officer
Sold after exercise
49,298
$24.00
$1.18M
Samuel Bates Martin
14 Jun 2024
SVP and CFO
Sold after exercise
17,172
$35.42
$608.31K
Elizabeth Crowley
14 Jun 2024
Sr. VP & Cpdo
Sold after exercise
30,000
$34.87
$1.05M
Elizabeth Crowley
7 Jun 2024
Sr. VP & Cpdo
Sold after exercise
15,000
$35.06
$525.87K
Freddy A. Jimenez
3 Jun 2024
SVP & General Counsel
Sold after exercise
8,006
$33.60
$269.00K
Richard M. Wright
3 Jun 2024
Sr. VP & CCO
Sold after exercise
19,264
$33.99
$654.69K
Richard M. Wright
3 Jun 2024
Sr. VP & CCO
Sold after exercise
27,580
$33.53
$924.66K
Margo Heath-Chiozzi
3 Jun 2024
SVP of Regulatory Affairs
Sold after exercise
58,369
$33.65
$1.96M
Elizabeth Crowley
30 May 2024
Sr. VP & Cpdo
Sold after exercise
38,597
$33.64
$1.30M
Sarah Cavanaugh
30 May 2024
SVP of Corp Affairs & Admin.
Sold after exercise
20,853
$33.73
$703.33K
Samuel Bates Martin
30 May 2024
SVP and CFO
Sold after exercise
35,000
$34.05
$1.19M
Margo Heath-Chiozzi
30 May 2024
SVP of Regulatory Affairs
Sold after exercise
38,719
$34.07
$1.32M
Tibor Keler
7 Dec 2022
Executive VP & CSO
Sold after exercise
16,860
$36.93
$622.61K
Sarah Cavanaugh
18 Aug 2022
SVP of Corp Affairs & Admin.
Sold after exercise
1,355
$36.38
$49.29K
Diane C. Young
17 Aug 2022
SVP, Chief Medical Officer
Sold after exercise
19,000
$37.30
$708.72K
Sarah Cavanaugh
17 Aug 2022
SVP of Corp Affairs & Admin.
Sold after exercise
31,312
$36.73
$1.15M
Richard M. Wright
15 Aug 2022
Sr. VP & CCO
Sold after exercise
15,328
$37.71
$578.05K
Anthony S Marucci
15 Aug 2022
President & CEO
Sold after exercise
120,000
$37.66
$4.52M
Samuel Bates Martin
12 Aug 2022
SVP and CFO
Sold after exercise
1,221
$34.62
$42.27K
Samuel Bates Martin
12 Aug 2022
SVP and CFO
Sold after exercise
2,065
$35.38
$73.05K
Samuel Bates Martin
12 Aug 2022
SVP and CFO
Sold after exercise
14,261
$36.76
$524.30K
Samuel Bates Martin
11 Aug 2022
SVP and CFO
Sold after exercise
2,453
$37.04
$90.86K
Samuel Bates Martin
23 Dec 2021
SVP and CFO
Sold after exercise
9,500
$42.00
$399.00K
Margo Heath-Chiozzi
8 Dec 2021
SVP of Regulatory Affairs
Sold after exercise
600
$40.00
$24.00K
Elizabeth Crowley
8 Dec 2021
Sr. VP &CPDO
Sold after exercise
4,000
$40.00
$160.00K
Sarah Cavanaugh
8 Dec 2021
SVP of Corp Affairs & Admin.
Sold after exercise
7,323
$40.00
$292.92K
Samuel Bates Martin
15 Nov 2021
SVP and CFO
Sold after exercise
2,048
$42.27
$86.57K
Samuel Bates Martin
15 Nov 2021
SVP and CFO
Sold after exercise
7,452
$43.92
$327.31K
Diane C. Young
12 Nov 2021
SVP, Chief Medical Officer
Sold after exercise
4,600
$42.94
$197.53K
Margo Heath-Chiozzi
1 Nov 2021
SVP of Regulatory Affairs
Sold after exercise
600
$41.71
$25.03K
Elizabeth Crowley
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
1,189
$41.62
$49.48K
Elizabeth Crowley
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
600
$43.11
$25.87K
Elizabeth Crowley
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
2,528
$44.12
$111.53K
Sarah Cavanaugh
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
2,120
$41.62
$88.23K
Sarah Cavanaugh
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
901
$43.06
$38.80K
Sarah Cavanaugh
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
4,302
$44.11
$189.77K
Samuel Bates Martin
10 Aug 2021
SVP and CFO
Sold after exercise
682
$45.25
$30.86K
Samuel Bates Martin
10 Aug 2021
SVP and CFO
Sold after exercise
2,056
$45.25
$93.03K
Richard M. Wright
14 Dec 2020
Sr. VP & CCO
Sold after exercise
9,375
$18.61
$174.44K
Richard M. Wright
14 Dec 2020
Sr. VP & CCO
Sold after exercise
11,457
$18.61
$213.17K
Show all 65 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,008,121
History held since 8 Jan 2007